Home › Post-COVID Conditions (Long COVID) › Minnesota
Pag-aaral pangklinika para sa Post-COVID Conditions (Long COVID) sa Minnesota
6 pag-aaral para sa Post-COVID Conditions (Long COVID) ang naghahanap ng mga kalahok sa mga site sa Minnesota.
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Mankato Clinic ( Site 3842), Mankato
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Saint Paul
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05624450Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of Minnesota, Minneapolis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06631287Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Mayo Clinic Rochester, Rochester
Nagre-recruitPhase 3
Lahat ng edad · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT03808922A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
- Mayo Clinic Minnesota, Rochester
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT06006884EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- Childrens Hospitals and Clinics of Minnesota, Minneapolis
Nagre-recruitPhase 3
Edad 0 hanggang 17 · Lahat ng kasarian · Na-update Hul 17, 2025 · NCT05261139Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.